OraSure Technologies Reaffirms Q4 Outlook

(RTTNews) - OraSure Technologies, Inc. (OSUR) said Monday that it was reaffirming its fourth quarter outlook, which was last updated on November 21.

The company said it continues to expect net revenues of $27.5million to $28.0 million and earnings of $0.07 - $0.08 per share for the fourth quarter of 2013.

Analysts polled by Thomson Reuters currently expect the company to report a loss of $0.04 per share on revenue of $27.70 million for the fourth quarter.

The company said the reaffirmation was being made after it learned that a customer of its molecular collection systems subsidiary, DNA Genotek, received a warning letter from the U.S. Food and Drug Administration requesting that that customer immediately discontinue marketing its service in the U.S.

The customer represented less than 5% of OraSure's 2013 consolidated net revenues through September 30, 2013.